Screening for Obstructive Sleep Apnea in Medical Patients

Withdrawn

• Conditions: Obstructive Sleep Apnea

• Registration Number: NCT05980936
• Lead Sponsor: Jordan Collaborating Cardiology Group

Brief Summary

Obstructive sleep apnea (OSA) is highly prevalent in the general population and is associated with multiple adverse cardiovascular consequences.

Screening for OSA is recommended in those with typical symptoms, such as daytime sleepiness, loud snoring, or abrupt awakenings with gasping or choking. Patients admitted to the general medical wards with these symptoms will be evaluated for the possibility of having OSA.

Detailed Description

Obstructive sleep apnea (OSA) is a disease that is highly prevalent in all communities and is associated with adverse cardiovascular events.

Screening for OSA is recommended in men and women who have the typical symptoms, including snoring, daytime sleepiness, or abrupt awakenings with choking or gasping.

OSA screening is also recommended for those with resistant hypertension, bradyarrhythmias, and atrial fibrillation.

Heart failure patients should also be screened for OSA. It is very important to increase the use of OSA screening especially in patients admitted to the medical floor in tertiary care hospitals. No study has evaluated this topic in the Middle East in the past.

Study Timeline

• Study First Submitted: 2023-07-20
• Study First Submitted QC: 2023-08-07
• Study First Posted: 2023-08-08
• Study Start: 2023-10-15
• Status Verified: 2025-02
• Primary Completion: 2025-02-15
• Study Completion: 2025-02-22
• Last Update Submitted: 2025-02-23
• Last Update Posted: 2025-02-25

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Willing to sign an informed consent
• Patient is admitted to the medical ward in a tertiary hospital

Exclusion Criteria

• Patients known to have obstructive sleep apnea.
• Patients younger than 18 years of age

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of Participants who are found to have obstructive sleep apnea	From date of study enrollment until the date of first documented diagnosis of obstructive sleep apnea, assessed up to 4 weeks.	Those who are found to have symptoms of OSA will be referred for further evaluation to get the final diagnosis of OSA

Trial Locations

Locations (2)

Ayman Hammoudeh; 🇯🇴 Amman, Jordan

Istishari Hospital; 🇯🇴 Amman, Jordan